# Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors

> **NCT00195260** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 151 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** bosutinib
- **DRUG:** bosutinib
- **DRUG:** bosutinib
- **DRUG:** bosutinib

## Key facts

- **NCT ID:** NCT00195260
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195260, "Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00195260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*